Analysis of Barrett’s Esophagus and Its Risk Factors: A Cross-Sectional Study of 10,122 Subjects at a Japanese Health Examination Center

Author:

Kubota DaiORCID,Takahashi YuORCID,Yamamichi Nobutake,Matsui Maki,Shimamoto Takeshi,Minatsuki Chihiro,Nakagawa Hideki,Mizutani Satoru,Tsuji YosukeORCID,Sakaguchi YoshikiORCID,Tamura NaokiORCID,Yakabi Seiichi,Ohki Daisuke,Mizutani Hiroya,Niimi Keiko,Wada Ryoichi,Fujishiro MitsuhiroORCID

Abstract

<b><i>Introduction:</i></b> <i>Helicobacter pylori</i> eradication is expected to significantly change the prevalence of Barrett’s esophagus (BE). However, few reports on this relationship exist. We analyzed the risk factors of BE using the current consensus on length of BE considering <i>H. pylori</i> infection status. <b><i>Methods:</i></b> We analyzed 10,122 individuals (5,962 men; mean age = 52.9 ± 9.9 years) who had undergone esophagogastroduodenoscopy as part of a medical checkup. Correlations among factors including <i>H. pylori</i> infectious status, endoscopic findings, and BE ≥1 cm were analyzed. <b><i>Results:</i></b> Prevalence of BE, long-segment BE, and esophageal adenocarcinoma was 22.5%, 0.014%, and 0%, respectively. Logistic regression analysis showed that the risk factors for BE were hiatal hernia (odds ratio [OR]: 2.89 [2.59–3.24]), female sex (OR: 0.52 [0.46–0.59]), social drinking (OR:0.77 [0.68–0.87]), <i>H. pylori</i> eradication therapy (OR: 1.34 [1.19–1.51]), proton pump inhibitor (PPI) use (OR: 1.52 [1.18–1.96]), bile reflux (OR: 1.18 [1.04–1.33]), age ≥50 years (OR: 1.13 [1.02–1.26]), and nonsteroidal anti-inflammatory drug (NSAID) use (OR: 1.29 [1.02–1.62]). Although reflux esophagitis (RE) was more common in <i>H. pylori</i>-negative patients (17.2%) than in those after <i>H. pylori</i> eradication therapy (11.8%, <i>p</i> &#x3c; 0.00001), the latter was correlated with BE, disputing RE as a strong risk factor for BE. Therefore, we conducted a subgroup analysis; most of the risk factors except for PPI use (<i>p</i> = 0.75), H2-receptor antagonist use (<i>p</i> = 0.078), and atrophic gastritis absence (<i>p</i> = 0.72) were positively correlated with BE after <i>H. pylori</i> eradication therapy compared with <i>H. pylori</i>-negative status. <b><i>Conclusions:</i></b> <i>H. pylori</i> eradication, bile reflux, PPI use, and NSAID use were risk factors for BE along with hiatal hernia, male sex, and older age.

Publisher

S. Karger AG

Subject

Gastroenterology

Reference55 articles.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3